Bonus Biogroup Ltd. is a biotechnology company, which engages in the field of stem cells and tissue engineering. The firm is developing cell therapy products based on autologous and allogeneic bone implants that will enable efficient bone transplant and provide cellular-based bone replacement prosthetics for repairing bone lesions. The company is targeting a worldwide market for the treatment of major disorders such as bone and cartilage related arthritis, osteoporosis, and various types of bones and joint trauma such as hip fractures and knee injuries, among others. On April 29, 2012, Bonus Bio Group Ltd fully acquired Bonus Therapeutic Ltd.
Follow-Up Questions
Who is the CEO of Bonus Biogroup Ltd?
Dr. Shai Meretzki is the Chief Executive Officer of Bonus Biogroup Ltd, joining the firm since 2012.
What is the price performance of BBIXF stock?
The current price of BBIXF is $0.08, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Bonus Biogroup Ltd?
Bonus Biogroup Ltd belongs to Biotechnology industry and the sector is Health Care
